Anti-IDH1 monoclonal antibody (DCABH-608)
Mouse anti-Human IDH1 monoclonal antibody for WB, IHC-P, ICC/IF, FC
Bring this labeled antibody directly to your bench!
Online Inquiry Add to basket
Protein expressed in 293T cell transfected with Human Isocitrate dehydrogenase expression vector.
WB: 1/2000; IHC-P: 1/50; ICC/IF: 1/100; Flow Cyt: 1/100;
*Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own experiment using appropriate negative and positive controls.
IDH1; isocitrate dehydrogenase 1 (NADP+), soluble; isocitrate dehydrogenase [NADP] cytoplasmic; NADP(+)-specific ICDH; oxalosuccinate decarboxylase; NADP-dependent isocitrate dehydrogenase, cytosolic
Citrate cycle (TCA cycle), organism-specific biosystem; Citrate cycle (TCA cycle), conserved biosystem; Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate, organism-specific biosystem; Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate, conserved biosystem; Glutathione metabolism, organism-specific biosystem;
Have you cited DCABH-608 in a publication? Let us know
and earn a reward for your research.
Stoczynsica-Fidelus, E; Och, W; et al. Spontaneous In Vitro Senescence of Glioma Cells Confirmed by an Antibody Against IDH1(R132H). ANTICANCER RESEARCH 34:2859-2867(2014).
Kaneko, MK; Liu, X; et al. Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone. CANCER SCIENCE 105:744-748(2014).
Custom Antibody Labeling
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody.